155 related articles for article (PubMed ID: 37590231)
1. A Multifunctional Delivery System for Remodulating Cell Behaviors of Circulating Malignant Cells to Prevent Cell Fusion.
Han D; He XY; Huang Y; Gao M; Guo T; Ren XH; Liao XR; Chen XS; Pang X; Cheng SX
Adv Sci (Weinh); 2023 Oct; 10(29):e2303309. PubMed ID: 37590231
[TBL] [Abstract][Full Text] [Related]
2. Multifunctional Vector for Delivery of Genome Editing Plasmid Targeting β-Catenin to Remodulate Cancer Cell Properties.
He XY; Liu BY; Peng Y; Zhuo RX; Cheng SX
ACS Appl Mater Interfaces; 2019 Jan; 11(1):226-237. PubMed ID: 30540162
[TBL] [Abstract][Full Text] [Related]
3. Self-Assembled Plasmid Delivery System for PPM1D Knockout to Reverse Tumor Malignancy.
Ren XH; He XY; Liu BY; Xu C; Cheng SX
ACS Appl Bio Mater; 2020 Nov; 3(11):7831-7839. PubMed ID: 35019523
[TBL] [Abstract][Full Text] [Related]
4. Aptamer/Peptide-Functionalized Genome-Editing System for Effective Immune Restoration through Reversal of PD-L1-Mediated Cancer Immunosuppression.
He XY; Ren XH; Peng Y; Zhang JP; Ai SL; Liu BY; Xu C; Cheng SX
Adv Mater; 2020 Apr; 32(17):e2000208. PubMed ID: 32147886
[TBL] [Abstract][Full Text] [Related]
5. Peptide and Aptamer Decorated Delivery System for Targeting Delivery of Cas9/sgRNA Plasmid To Mediate Antitumor Genome Editing.
Liu BY; He XY; Xu C; Ren XH; Zhuo RX; Cheng SX
ACS Appl Mater Interfaces; 2019 Jul; 11(27):23870-23879. PubMed ID: 31257851
[TBL] [Abstract][Full Text] [Related]
6. A multifunctional non-viral vector for the delivery of MTH1-targeted CRISPR/Cas9 system for non-small cell lung cancer therapy.
Wang Y; Tang Y; Zhao XM; Huang G; Gong JH; Yang SD; Li H; Wan WJ; Jia CH; Chen G; Zhang XN
Acta Biomater; 2022 Nov; 153():481-493. PubMed ID: 36162766
[TBL] [Abstract][Full Text] [Related]
7. A Dual-Targeting Delivery System for Effective Genome Editing and In Situ Detecting Related Protein Expression in Edited Cells.
Liu BY; He XY; Xu C; Xu L; Ai SL; Cheng SX; Zhuo RX
Biomacromolecules; 2018 Jul; 19(7):2957-2968. PubMed ID: 29617556
[TBL] [Abstract][Full Text] [Related]
8. Tumor targeted genome editing mediated by a multi-functional gene vector for regulating cell behaviors.
Liu BY; He XY; Zhuo RX; Cheng SX
J Control Release; 2018 Dec; 291():90-98. PubMed ID: 30339905
[TBL] [Abstract][Full Text] [Related]
9. Functional Tumor Targeting Nano-Systems for Reprogramming Circulating Tumor Cells with In Situ Evaluation on Therapeutic Efficiency at the Single-Cell Level.
Ren XH; He XY; Xu C; Han D; Cheng SX
Adv Sci (Weinh); 2022 Jul; 9(21):e2105806. PubMed ID: 35595716
[TBL] [Abstract][Full Text] [Related]
10. Aptamer/Peptide-Functionalized Nanoprobe for Detecting Multiple miRNAs in Circulating Malignant Cells to Study Tumor Heterogeneity.
Han D; Ren XH; He XY; Chen XS; Pang X; Cheng SX
ACS Biomater Sci Eng; 2023 Oct; 9(10):5832-5842. PubMed ID: 37679307
[TBL] [Abstract][Full Text] [Related]
11. EGFR and CD44 Dual-Targeted Multifunctional Hyaluronic Acid Nanogels Boost Protein Delivery to Ovarian and Breast Cancers In Vitro and In Vivo.
Chen J; Ouyang J; Chen Q; Deng C; Meng F; Zhang J; Cheng R; Lan Q; Zhong Z
ACS Appl Mater Interfaces; 2017 Jul; 9(28):24140-24147. PubMed ID: 28675028
[TBL] [Abstract][Full Text] [Related]
12. A novel dual-targeting delivery system for specific delivery of CRISPR/Cas9 using hyaluronic acid, chitosan and AS1411.
Khademi Z; Ramezani M; Alibolandi M; Zirak MR; Salmasi Z; Abnous K; Taghdisi SM
Carbohydr Polym; 2022 Sep; 292():119691. PubMed ID: 35725215
[TBL] [Abstract][Full Text] [Related]
13. GE11 peptide conjugated selenium nanoparticles for EGFR targeted oridonin delivery to achieve enhanced anticancer efficacy by inhibiting EGFR-mediated PI3K/AKT and Ras/Raf/MEK/ERK pathways.
Pi J; Jiang J; Cai H; Yang F; Jin H; Yang P; Cai J; Chen ZW
Drug Deliv; 2017 Nov; 24(1):1549-1564. PubMed ID: 29019267
[TBL] [Abstract][Full Text] [Related]
14. Multi-Targeting Nano-Systems Targeting Heterogeneous Cancer Cells for Therapeutics and Biomarker Detection.
Ren XH; Han D; He XY; Guo T; Chen XS; Pang X; Cheng SX
Adv Healthc Mater; 2023 Feb; 12(4):e2202155. PubMed ID: 36333906
[TBL] [Abstract][Full Text] [Related]
15. Challenges for the application of EGFR-targeting peptide GE11 in tumor diagnosis and treatment.
Hailing T; Yonghong P; Yufeng Z; Haitao T
J Control Release; 2022 Sep; 349():592-605. PubMed ID: 35872181
[TBL] [Abstract][Full Text] [Related]
16. Reversal of tumor malignization and modulation of cell behaviors through genome editing mediated by a multi-functional nanovector.
Liu BY; He XY; Zhuo RX; Cheng SX
Nanoscale; 2018 Dec; 10(45):21209-21218. PubMed ID: 30417194
[TBL] [Abstract][Full Text] [Related]
17. CRISPR/Cas9-mediated Generation of Human Endothelial Cell Knockout Models of CCM Disease.
Schwefel K; Spiegler S; Much CD; Felbor U; Rath M
Methods Mol Biol; 2020; 2152():169-177. PubMed ID: 32524552
[TBL] [Abstract][Full Text] [Related]
18. Retro-inverso d-peptide-modified hyaluronic acid/bioreducible hyperbranched poly(amido amine)/pDNA core-shell ternary nanoparticles for the dual-targeted delivery of short hairpin RNA-encoding plasmids.
Gu J; Chen X; Fang X; Sha X
Acta Biomater; 2017 Jul; 57():156-169. PubMed ID: 28442415
[TBL] [Abstract][Full Text] [Related]
19. A targeting delivery system for effective genome editing in leukemia cells to reverse malignancy.
Ren XH; Xu C; Li LL; Zuo Y; Han D; He XY; Cheng SX
J Control Release; 2022 Mar; 343():645-656. PubMed ID: 35157940
[TBL] [Abstract][Full Text] [Related]
20. Chimeric virus-like particles (VLPs) designed from shrimp nodavirus (MrNV) capsid protein specifically target EGFR-positive human colorectal cancer cells.
Grataitong K; Huault S; Chotwiwatthanakun C; Jariyapong P; Thongsum O; Chawiwithaya C; Chakrabandhu K; Hueber AO; Weerachatyanukul W
Sci Rep; 2021 Aug; 11(1):16579. PubMed ID: 34400669
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
